Medications are associated with development of adverse drug events (ADEs), some more
than others, due to alteration in pharmacokinetics and dynamics with age. Phenytoin
efficacy and toxicity relate to drug levels, interaction with cytochrome P450, hepatic
function and albumin levels; phenytoin is largely protein bound. Our case illustrates
the difficulties in dosing phenytoin in a long-term care resident.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the American Medical Directors AssociationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2022 Published by Elsevier Inc.
